Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ROPINIROLE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ROPINIROLE EXTENDED-RELEASE TABLETS. ROPINIROLE extended-release tablets, for oral use Initial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
Ropinirole extended-release tablets are indicated for the treatment of Parkinson’s disease.
- generic_name
- ropinirole
- product_names
- Ropinirole
- ndc
- 62332-107, 62332-108, 62332-109, 62332-110, 62332-111, 62332-107-30, 62332-107-90, 62332-107-31, 62332-107-71, 62332-107-91, 62332-107-10, 62332-108-30, 62332-108-90, 62332-108-31, 62332-108-71, 62332-108-91, 62332-108-10, 62332-109-30, 62332-109-90, 62332-109-31, 62332-109-71, 62332-109-91, 62332-109-10, 62332-110-30, 62332-110-90, 62332-110-31, 62332-110-71, 62332-110-91, 62332-110-10, 62332-111-30, 62332-111-90, 62332-111-31, 62332-111-71, 62332-111-91, 62332-111-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en